ConductScience.org, home

Paper7296751

Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.

Formelli F and 4 others. Cancer Chemother Pharmacol, 1981. Cited by 35 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors. Papers, record 7296751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7296751

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2019-08-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Formelli FF
2Pollini CC
3Casazza AMA M
4di Marco AA
5Mariani AA

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
DoxorubicinMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Kinetics
Male
Mice
Mice, Inbred BALB C
Spectrometry, Fluorescence
Time Factors
Tissue Distribution

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15527015Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods.Cancer Chemother Rep1970https://conductscience.org/library/papers/5527015PubMed
2597963Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.Chem Biol Interact1977https://conductscience.org/library/papers/597963PubMed
35266065Adriamycin: toxicity data.Experientia1970https://conductscience.org/library/papers/5266065PubMed
4294954Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/294954PubMed
54715566A fluorometric assay for daunomycin and adriamycin in animal tissues.Biochem Med1973https://conductscience.org/library/papers/4715566PubMed
6206445Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma.Eur J Cancer (1965)1978https://conductscience.org/library/papers/206445PubMed
71003430Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin.J Med Chem1976https://conductscience.org/library/papers/1003430PubMed
84427218Statistical estimations in pharmacokinetics.J Pharmacokinet Biopharm1974https://conductscience.org/library/papers/4427218PubMed
95030818Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.Cancer Res1972https://conductscience.org/library/papers/5030818PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
38222540Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach.ACS Omega2024https://conductscience.org/library/papers/38222540PubMed
6678877Phase I trial with 4'-deoxydoxorubicin (esorubicin).Invest New Drugs1983https://conductscience.org/library/papers/6678877PubMed
6511235Phase I study with 4'-deoxydoxorubicin.Invest New Drugs1984https://conductscience.org/library/papers/6511235PubMed
4086243Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin).Invest New Drugs1985https://conductscience.org/library/papers/4086243PubMed
4017162Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4017162PubMed
3753554Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3753554PubMed
3520474Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci1986https://conductscience.org/library/papers/3520474PubMed
3484382Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3484382PubMed
2948729Anthracycline analogs: the past, present, and future.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/2948729PubMed
2283890Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and rats.Med Oncol Tumor Pharmacother1990https://conductscience.org/library/papers/2283890PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7296751

GET https://conductscience.org/api/papers/v1/7296751/authors